Richard Rodgers
Direttore/Membro del Consiglio presso ARDELYX, INC.
Patrimonio netto: 2 M $ in data 30/04/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
David Mott | M | 58 | 15 anni | |
George Kemble | M | 63 | 13 anni | |
John Trizzino | M | 64 | 10 anni | |
Elizabeth Grammer | F | 60 | 12 anni | |
James Young | M | 71 | 14 anni | |
Merdad Parsey | M | 61 | 14 anni | |
Justin Renz | M | 52 | 4 anni | |
Beth Seidenberg | M | 67 | 17 anni | |
David Happel | M | 62 | 2 anni | |
Mike Raab Raab | M | 59 | 15 anni | |
Amy Rabourn | F | 44 | 5 anni | |
Cam Gallagher | M | 54 | 5 anni | |
John Jacobs | M | 57 | 1 anni | |
Bernhard Hoffmann | M | 68 | 6 anni | |
Robert Felsch | M | - | 4 anni | |
Laura Williams | M | 61 | 4 anni | |
Muna Bhanji | F | 61 | 3 anni | |
George Magrath | M | 40 | 1 anni | |
Erik Sims | M | - | 3 anni | |
Brian Rosen | M | - | 9 anni | |
Jay Pepose | M | 69 | 3 anni | |
Sean Ainsworth | M | 56 | 6 anni | |
Robert B. Bazemore | M | 56 | 8 anni | |
Caitlin Lowie | F | - | 2 anni | |
Silvia Taylor | F | - | 4 anni | |
James Kelly | M | 58 | 3 anni | |
Elizabeth Rozek | F | 53 | 1 anni | |
Onaiza Cadoret-Manier | F | 60 | 4 anni | |
James Armitage | M | 77 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 14 anni |
Gale Smith | M | - | 20 anni | |
William Bertrand | M | 59 | 9 anni | |
Susan Benton | F | 59 | 4 anni | |
Gregg Alton | M | 58 | 4 anni | |
Richard Douglas | M | 71 | 14 anni | |
Jan Lundberg | M | 70 | 6 anni | |
Mark Joseph Casey | M | 60 | 1 anni | |
Rachel King | F | 64 | 6 anni | |
James Manuso | M | 75 | 5 anni | |
Margaret McGlynn | F | 64 | 4 anni | |
Nirav Jhaveri | M | 46 | - | |
Raburn Mallory | M | - | 4 anni | |
Troy Morgan | M | - | 3 anni | |
Denny Kim | M | - | 3 anni | |
Johann Bono | M | - | - | |
Ursula Matulonis | F | - | - | |
Duncan Jodrell | M | - | - | |
Seth Toback | M | - | 4 anni | |
Barbara Withers | F | - | - | |
Erika Schultz | F | - | - | |
Ronil Patel | M | - | 3 anni | |
Arnold Lewis Oronsky | M | 83 | 13 anni | |
Frank D. Czworka | M | 55 | 4 anni | |
Henrietta Ukwu | M | 64 | 3 anni | |
Drey Coleman | F | - | - | |
Anne-Marie O'Farrell | M | - | 11 anni | |
Robert Blanks | M | 64 | 11 anni | |
Filip Dubovsky | M | 59 | 4 anni | |
Biegie Lee | M | - | 7 anni | |
Chris Dunne | M | - | 14 anni | |
David Rosenbaum | M | 63 | 14 anni | |
Gaeton Biscardi | M | - | - | |
Mitchell Brigell | M | - | - | |
Joseph Schachle | M | 59 | 1 anni | |
Iksung Cho | M | - | 9 anni | |
Timothy Jon Hahn | M | 60 | 4 anni | |
Alison Chartan | F | - | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Mary Lynne Hedley | M | 61 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 16 anni |
Douglas Swirsky | M | 54 | 2 anni | |
Lonnie Moulder | M | 66 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | 10 anni |
Mina Sooch | F | 56 | 5 anni | |
Chang Ho Ahn | M | 72 | 16 anni | |
Gordon Ringold | M | 73 | 14 anni | |
Mark E. Kaufmann | M | 56 | 9 anni | |
Stanley Erck | M | 76 | 14 anni | |
Joseph Oriti | M | 44 | - | |
John Herrmann | M | 58 | 13 anni | |
Anthony Rimac | M | 60 | 1 anni | |
Patrick Soon-Shiong | M | 71 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | 3 anni |
Dominique Charmot | M | 69 | 7 anni | |
Richard R. Roscitt | M | 72 | 2 anni | |
Tae Heum Jeong | M | 53 | 15 anni | |
Edward C. English | M | 57 | 5 anni | |
Peter G. Schultz | M | 67 | 8 anni | |
Jennifer Davis Ruff | F | - | 5 anni | |
Jill Hoyt | F | - | 15 anni | |
Rakesh Soni | M | 68 | 7 anni | |
Si Moon Hwang | M | 55 | 3 anni | |
Keith Santorelli | M | - | - | |
Annalisa Jenkins | M | 58 | 5 anni | |
Geoffrey A. Block | M | 58 | 4 anni | |
Paul Walker | M | 49 | 4 anni | |
Jeffrey W. Jacobs | M | 61 | 13 anni | |
Eric P. Loukas | M | 67 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 7 anni |
Jean M. Fréchet | M | - | 7 anni | |
David Martin McIntosh | M | 65 | 11 anni | |
David Collier | M | 61 | - | |
William Cadogan | M | 75 | 14 anni | |
Russell Wilson | M | 64 | 12 anni | |
Peter David Suzdak | M | 65 | 5 anni | |
David F. Fisher | M | 75 | 5 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Richard Rodgers
- Contatti personali